Background-Severe asthma is characterized by persistent airway inflammation and increased formation of reactive oxygen species.
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Asthma; children; glutathione; 8-isoprostanes; hydrogen peroxide; malondialdehyde; oxidative stress; redox potential Severe refractory asthma is a complex disorder characterized by airway hyperresponsiveness, obstructive changes in pulmonary function, and persistent airway inflammation despite highdose inhaled corticosteroid (ICS) treatment. 1-3 Although the inflammatory response is important for the initiation of tissue repair, the exaggerated responses associated with severe asthma result in excessive reactive oxygen species formation and tissue destruction. 4 This resulting imbalance between pro-oxidant and antioxidant forces leads to an ongoing cycle of inflammation in the asthmatic airway that ultimately contributes to irreversible airway injury. 5
Glutathione (GSH), a tripeptide thiol, is an abundant airway antioxidant 6 which reduces organic hydroperoxides and protects the airway from lipid peroxidation. 7 In response to hydroperoxides, GSH is released by glutathione S-transferase (GST) and becomes oxidized through a reaction involving glutathione peroxidase (GPx). This process forms glutathione disulfide (GSSG), which can be reduced to GSH by an nicotinamide adenine dinucleotide phosphate (NADPH)-dependent glutathione reductase (GR) reaction (Fig 1) . The relationship between GSH and GSSG is a critical regulator of cellular processes and antioxidant defense. With excessive GSSG accumulation, airway GSH homeostasis is altered, resulting in impaired cellular signaling and increased susceptibility to lung injury. [8] [9] [10] Although GSH homeostasis has been previously assessed in the blood, 11 sputum, 12 and bronchoalveolar lavage (BAL) 13 of subjects with mild asthma, no study to date has directly examined airway GSH concentrations in patients with severe asthma. The purpose of this study was to quantify epithelial lining fluid (ELF) GSH homeostasis in children with severe asthma. We hypothesized that children with severe asthma would have increased airway GSSG and greater generalized airway oxidation as measured by increased H 2 O 2 , malondialdehyde, and 8-isoprostanes.
METHODS Sample
A convenience sample of children with severe asthma 5 to 17 years of age attending a difficult asthma clinic at Emory University were recruited for this study. Participants were clinically stable and were under the care of a pediatric pulmonary specialist. Participants underwent flexible bronchoscopy as indicated for persistent asthma symptoms despite appropriate treatment with high-dose inhaled and systemic corticosteroids. 14 The subsequent BAL sample was divided between the research and clinical laboratories according to a protocol approved by the local Institutional Review Board. Informed consent was obtained from all caregivers. Children also provided verbal and written assent.
Children with severe asthma met published criteria for persistent asthma 15 and had at least a 12% change in FEV 1 after short-acting bronchodilator administration. Severe asthma was diagnosed according to criteria developed by the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program 2 based on an American Thoracic Society consensus panel report (see this article's Table E1 in the Online Repository at www.jacionline.org). 16 Thresholds for high-dose ICS were adjusted for children and defined as ≥440 μg of fluticasone equivalent per day for children younger than 12 years and ≥880 μg for children 12 to 17 years. 15 All children with asthma were treated with a stable dose of ICS or oral corticosteroids for at least 8 weeks before bronchoscopy. Children with immunodeficiency, history of premature birth, or other pulmonary morbidities were excluded. Subjects with asthma were screened for corticosteroid adherence. Known comorbid conditions associated with asthma including sinus infection, sleep disorders, and gastroesophageal reflux were addressed before bronchoscopy.
Controls for this study were recruited from 2 populations: (1) children with psychogenic (habit) cough or vocal cord dysfunction, and (2) healthy, nonsmoking adult volunteers. Control children had no family history of asthma, a negative bronchodilator response, no evidence of aeroallergen sensitivity, and normal exhaled nitric oxide (F ENO ) concentrations. Adults serving as controls were nonsmokers with no known pulmonary disorders and no respiratory symptoms.
Procedures
Spirometry was performed with a portable spirometer (KoKo Legend; Ferraris, Louisville, Colo) according to American Thoracic Society criteria for reproducibility 17 and was interpreted according to population reference standards. 18 F ENO was collected with a reservoir bag at a fixed exhaled flow rate of 0.35 L/s and analyzed offline by chemiluminescence (Sievers NOA 280-I; Ionic Instruments, Boulder, Colo). 19 Nicotine exposure was verified in healthy adult controls using a urinary cassette test (Accutest; Jant Pharmacal, Encino, Calif) with a cotinine cutoff of 200 ng/mL. Venipuncture was performed in all participants immediately before bronchoscopy for plasma urea determination.
Bronchoscopy in pediatric participants was performed by pediatric pulmonologists using a laryngeal mask airway or endotracheal tube and inhaled sevoflurane. BAL fluid was collected from the right middle lobe with three 1-mL/kg (50 mL maximum) saline lavages flushed through the suction channel of a flexible bronchoscope (Olympus BF-3C160 [3.7 mm] or BF-P160 [4.9 mm]; Olympus America Inc, Melville, NY). Bronchoscopy was performed in adults by physicians trained in pulmonary and critical care medicine using a flexible bronchoscope (Olympus BF-1T20D, Olympus America) passed transnasally into the right middle lobe. Subjects received intravenous midazolam and fentanyl for the procedure. Three 50-mL saline aliquots were instilled and immediately aspirated. The BAL from all participants was pooled under continuous low pressure suction. In children, the BAL return volume was divided between the research and clinical laboratories. The samples submitted to the clinical laboratories were subjected to standard culture and sensitivity testing, viral respiratory panels, and cytopathological stains for bacteria and fungi.
Bronchoalveolar lavage fluid was centrifuged at 1200 rpm for 7 minutes at 4°C to separate the supernatant and cellular fractions. The supernatant was removed and divided into 250-μL aliquots. To prevent auto-oxidation of the samples during storage, 1 sample aliquot was preserved immediately after collection for GSH and GSSG analysis in a 5% perchloric acid solution containing iodoacetic acid (6.7 μmol/L) and boric acid (0.1 mol/L) with 5 μmol/L γglutamyl-glutamate internal standard. 20 A second sample aliquot was preserved in 5 μL 2.5 mg/mL butylated hydroxytoluene for 8-isoprostane measurement. Aliquots were stored at −80°C before analysis. The cell pellet was resuspended in 1 mL Dulbecco modified Eagle medium containing 10% FCS. Total cell counts were performed manually with a hemocytometer. Cellular differentials were assessed after Wright staining.
The protein content of the BAL supernatant was assessed using a Coomassie (Bradford) protein assay (Pierce Biotechnology, Rockford, Ill) with a detection limit of 1 μg/mL at an absorbance of 595 nm. Urea nitrogen was measured in plasma and BAL supernatant by using a quantitative colorimetric assay (Pointe Scientific, Canton, Mich) with sensitivity of 0.05 to 150 mg/dL. The dilution of the BAL was calculated from (urea) plasma /(urea) BAL 21 . Enzymatic activities of GST, GR, and GPx were quantified in the BAL supernatant with commercially available assay kits (Cayman Chemical, Ann Arbor, Mich). For GST, samples were concentrated to a molecular weight cutoff of 3000. GST activity was determined after conjugation of 1-chloro-2,4-dinitrobenzene (CDNB) with GSH. GST activity was analyzed over a period of 5 minutes at 340 nm with a CDNB extinction coefficient of 0.0096 μmol/ L −1 cm −1 . GR and GPx samples were concentrated to a 10,000 molecular weight cutoff. GR activity was determined by the rate of NADPH oxidation, and GPx activity was determined through a coupled reaction with GR. GR and GPx activities were analyzed over a period of 5 minutes at 340 nm absorbance with an NADPH extinction coefficient of 0.00622 μmol/ L −1 cm −1 . Each assay had a wavelength accuracy of ±2 nm with repeatability of ±0.2 nm.
Malondialdehyde concentrations were determined in the BAL supernatant with a spectrophotometric assay (Bioxytech MDA-586; Oxis International, Foster City, Calif) at 586 nm absorbance with a detection limit A 586 of 0.0088. This assay is based on the reaction of Nmethyl-2-phenylindole with malondialdehyde at 25°C. 8-Isoprostane concentrations were obtained by ELISA (Cayman Chemical, Ann Arbor, Mich) with absorbance at 420 nm and detection limit of approximately 2.7 pg/mL. H 2 O 2 concentrations were determined spectrophotometrically from a microplate assay kit (Amplex Red; Molecular Probes, Eugene, Ore) with an excitation of 560 nm, fluorescence emission detection at 590 nm, and sensitivity of 50 nmol/L.
Statistical analysis
Data were analyzed with SPSS software (Version 15; SPSS Inc, Chicago, Ill). Children with severe asthma were stratified according to the baseline airway obstruction, defined as an FEV 1 <80% predicted or an FEV 1 :forced vital capacity (FVC) <0.80. 18 GSH, GSSG, malondialdehyde, 8-isoprostane, and H 2 O 2 concentrations were expressed per milliliter ELF according to the urea dilution 21 and were logarithmically transformed before statistical analysis given their nonnormal distribution. GST, GR, and GPx enzymatic activities were also expressed per mL of ELF and logarithmically transformed before analysis. Differences between groups were assessed by ANOVA with Tukey post hoc testing with significance defined as α ≤0.05. Bivariate Pearson correlations were used to examine associations between variables. To test the relationship between GSH oxidation and asthma severity, univariate logistic and linear regression analyses were performed by using the percentage of GSSG as the independent variable and measures of asthma severity, including hospitalization within the previous year, ICS dose, daily prednisone use, F ENO , FEV 1 , and FEV 1 bronchodilator reversibility as dependent variables. To evaluate factors that might affect GSH oxidation in the ELF, multivariate backward elimination linear regression was performed by using percent GSSG as the dependent variable and age, sex, ethnicity, ICS dose, prednisone dose, and the percentage of airway eosinophils and neutrophils as predictors. Multicollinearity between predictors was assessed with tolerance statistics. Entry and removal probabilities were set at . 05 and .10, respectively.
RESULTS
Seventy-four children with severe asthma, 13 pediatric controls, and 35 healthy adult controls were recruited for this study. After recruitment, 7 of the 13 pediatric controls were diagnosed with BAL colonization (n = 3) or chronic aspiration (n = 4) and were excluded from data analysis. Nine subjects with severe asthma also had BAL colonization with Streptococcus pneumoniae (n = 4), Haemophilus influenzae (n = 2), or Moraxella catarrhalis (n = 3) and were similarly excluded. Features of the excluded children appear in this article's Tables E2 to E4 in the Online Repository at www.jacionline.org. Although the clinical features of excluded children did not differ from those included in the final analysis, the excluded children did have greater evidence of ELF oxidant stress. Compared with pediatric controls, the children without asthma excluded from data analysis had lower GSH, lower total GSH + GSSG concentrations, a higher percentage of GSSG, and a more oxidized redox potential (E h ) in the ELF (Table E3 ). Likewise, the subjects with severe asthma excluded from the final analysis had lower GSH, higher GSSG, and a more oxidized redox potential compared with the subjects with severe asthma included in the final data analysis (Table E4 ).
The resulting pediatric control group contained 6 children. Postbronchoscopy diagnoses in this group included psychogenic (habit) cough (n =4) and vocal cord dysfunction (n =3). None of the children serving as controls were receiving ICS at the time of bronchoscopy. Given the symptomatic nature of these children, 35 healthy adults were also recruited for comparison. Adults in this control group were nonsmokers free of respiratory symptoms and medication use; however, they were significantly older ( Table I) .
Features of the groups appear in Table I . Children with severe asthma were stratified according to the baseline airway obstruction, defined as an FEV 1 <80% predicted or an FEV 1 to FVC ratio <0.80. 18 Subjects with severe asthma with airway obstruction (AO+) had increased bronchodilator reversibility with albuterol despite higher ICS doses and a greater prevalence of hospitalization within the previous year (Table I) .
Flexible bronchoscopy with BAL was well tolerated in all participants. Bronchospasm greater than 15 seconds was observed in 3 children with severe asthma and responded immediately to bronchodilators and positive airway pressure. No subject required overnight hospitalization or prolonged observation.
The composition of the BAL is presented in Table II . BAL samples from adult controls were characterized by larger return volumes and higher cell counts. Adult and pediatric controls also had significantly less protein and fewer neutrophils and eosinophils than subjects with severe asthma with (AO+) and without (AO−) airway obstruction (P <.05; Table II) .
GSH, GSSG, and GSH/GSSG redox potential in ELF
Compared with adult and pediatric control subjects, children with severe asthma had significantly lower total GSH + GSSG concentrations in the ELF (adult control: 436 ± 249 μmol/L; pediatric control: 260 ± 230 μmol/L; severe asthma [AO−]: 134 ±150 μmol/L; severe asthma [AO+]: 129 ± 134 μmol/L; P < .001 for severe asthma AO± vs adult controls, P=.07 for severe asthma AO± vs pediatric controls). In subjects with severe asthma with airway obstruction, the majority (~60%) of the total pool was in the oxidized (GSSG) form (Fig 2) .
Using the Nernst equation, the oxidative redox potential (E h ) for the GSH/GSSG pair was significantly more reduced in the adult controls compared with the other groups, with the greatest oxidation apparent in subjects with severe asthma with airway obstruction (Fig 2) .
Airway GST, GR, and GPx activities
To determine whether altered GSH-dependent enzymatic activities might account for increased GSH oxidation in severe asthma, GST, GR, and GPx were quantified in the ELF. GST activities (expressed per milliliter ELF) were similar between groups (adult control: 
Associations between GSH and other oxidative biomarkers
Malondialdehyde, 8-isoprostanes, and H 2 O 2 were significantly elevated in the ELF of subjects with severe asthma compared with adult and pediatric controls (Fig 3) . In subjects with severe asthma with and without airway obstruction, malondialdehyde, 8-isoprostanes, and H 2 O 2 were positively correlated with the percentage of airway GSSG and the oxidative redox potential (E h ) of the GSH:GSSG couple (P ≤.05 for each association; see this article's Table E5 in the Online Repository at www.jacionline.org).
Clinical predictors of GSH oxidation in subjects with severe asthma
Within the group of subjects with severe asthma, total GSH + GSSG concentrations were not associated with baseline FEV 1 or the presence of airway eosinophils or neutrophils. Total GSH + GSSG concentrations, the percentage of GSSG, and the redox potential (E h ) of the GSH:GSSG couple were significantly associated with baseline F ENO (GSH + GSSG: r = −0.60, P=.003; % GSSG: r = 0.480, P=.032; E h GSH:GSSG: r = 0.43, P=.047). To test the association between altered GSH homeostasis and clinical markers of asthma severity, univariate logistic and linear regression analyses were performed by using the percentage of GSSG as the predictor and hospitalization within the previous year, prednisone use, ICS dose, F ENO , baseline FEV 1 , and FEV 1 bronchodilator reversibility as dependent variables. Using this approach, hospitalization within the previous year (−2 log L = 61.49; P = .001) and baseline F ENO (R 2 = 0.230; P = .032) were significantly predicted by the percentage of GSSG (see this article's Tables E6 and E7 in the Online Repository at www.jacionline.org).
To evaluate factors that might affect airway GSSG formation, stepwise linear regression analysis was performed on children with severe asthma with the percentage of GSSG as the dependent variable and age, sex, ethnicity, ICS dose, prednisone dose, and the percentage of airway eosinophils and neutrophils as predictors. With the multivariate model, only sex (P=. 038) and airway eosinophils (P=.031) were predictive of airway GSH oxidation (final model R 2 = 0.322, P=.045; see this article's Table E8 in the Online Repository at www.jacionline.org).
DISCUSSION
This is the first study to provide a detailed assessment of airway GSH homeostasis in children with severe asthma. Total ELF GSH + GSSG concentrations were significantly lower in symptomatic children than in adult controls and were accompanied by greater GSH oxidation as measured by GSSG. GSSG was increased nearly 2-fold in subjects with severe asthma with airway obstruction and was further associated with increased malondialdehyde, 8-isoprostane, and H 2 O 2 concentrations. Enzymatic activities of GST, GR, and GPx were similar between groups and were not associated with ELF GSH levels. These results suggest that GSH homeostasis is altered in children with severe asthma as a function of increased ELF oxidation, which favors the conversion of GSH to GSSG and signals compromised antioxidant function.
GSH was first characterized in the ELF of healthy, nonsmoking adults nearly 20 years ago. In the classic study by Cantin et al, 6 total GSH + GSSG concentrations in the alveolar ELF of healthy adults were approximately 430 μmol/L, with less than 5% of the total pool in the oxidized (GSSG) form. Although smoking initially increases GSH concentrations, 6 long-term smoking has been associated with increased GSSG formation. 24 Similar increases in GSSG with resulting declines in GSH have been noted in adults with chronic alcoholism, 25,26 human immunodeficiency virus, 27 pulmonary fibrosis, 28,29 and acute respiratory distress syndrome. 30, 31 These studies suggest that ELF GSH homeostasis is disturbed in a variety of pulmonary disorders and may account for some of the respiratory morbidity associated with pulmonary disease.
Few studies have examined GSH homeostasis in asthma, and fewer still have measured GSH in the ELF. In an earlier study, Smith et al 32 noted that total GSH + GSSG concentrations in the ELF were higher in adults with mild asthma than controls. However, GSH concentrations were inversely correlated with bronchial hyperresponsiveness, suggesting a relationship between antioxidant defense and pulmonary function. 32 Although similar studies of steroidnaive subjects with mild asthma have shown no differences in baseline GSH concentrations as compared with controls, 13,33 baseline GSSG is elevated 13 and increases further with segmental antigen challenge. 33 These data suggest that airway oxidant stress is a defining feature of asthma that may be present in spite of normal clinical features.
The redox potential is a measure of the capacity to reduce reactive oxygen species where the more negative the number, the greater the reduction potential. We observed redox potentials in symptomatic children that were significantly lower than those of healthy adults. Children with severe asthma had ELF redox potentials that, on average, were approximately 75 mV more oxidized than adult controls. Other studies of plasma have suggested that the GSH redox potential increases in an age-dependent manner by 0.7 mV per year. 34,35 If a similar trend is present in ELF, then the oxidant stress observed in our sample of children with severe asthma is more similar to that of an older adult. Furthermore, a 75 mV shift in the GSH redox potential is more than sufficient to cause a 17-fold change in the ratios of reduced to oxidized forms of proteins such as thioredoxins. 23
This study has a number of limitations. Because bronchoscopy cannot be performed on asymptomatic children solely for research purposes, our pediatric control group was limited to symptomatic children with psychogenic cough or vocal cord dysfunction undergoing bronchoscopy for diagnostic purposes. It is therefore possible that the GSH concentrations we observed are not representative of those from healthy asymptomatic children. Similarly, because we were limited to a convenience sample of children with severe asthma, it is unclear whether ELF GSH concentrations differ in subjects with severe asthma who are well controlled on high doses of ICS and do not undergo bronchoscopy. The fact that our adult control group was significantly older also raises the question whether age is a determinant of antioxidant defense across the lifespan. Additional studies are needed before these questions can be adequately addressed.
It is also possible the differences in GSH homeostasis that we observed could be attributed to the confounding effects of asthma treatment or other clinical features. Although ICS dose was highly associated with GSH and oxidative biomarkers, ICS dose failed to predict GSH oxidation in multivariate analysis. The fact that ICS dose is a surrogate of severe asthma and the major criterion for diagnosis 16 likely accounts for this relationship. Alternatively, these data may indicate that corticosteroids alone are insufficient to counteract airway oxidant stress in this population. The elevated malondialdehyde, 8-isoprostane, and H 2 O 2 concentrations observed in subjects with severe asthma with airway obstruction also question the steroid sensitivity of this population. Additional studies are needed to examine thoroughly the relationship between GSH homeostasis, corticosteroid treatment, and clinical indicators of severe asthma in children.
For this study, we asked pediatric participants and their caregivers to list all current medications. We then questioned children and their parents about the specific dosages and frequency of administration. Although this method of medication assessment likely yielded accurate information regarding current asthma treatment, it may also have underestimated the use of over-the-counter medications such as acetaminophen. In a recent report from the International Study of Asthma and Allergies in Childhood, acetaminophen (paracetamol) use was associated with a dose-dependent increased risk of asthma symptoms in children 6 to 7 years of age. 36 This finding warrants further study. Acetaminophen is metabolized by cytochrome P450 to form the toxic species N-acetyl-p-benzoquinone imine, which is detoxified by GSH. With repeated acetaminophen use or excessive dosages, liver GSH stores are depleted, resulting in liver damage. 37 Future studies should consider the effects of acetaminophen use on altered airway GSH homeostasis, particularly in patients with severe asthma.
In summary, we have demonstrated significant alterations of GSH homeostasis in children with severe refractory asthma characterized by decreased GSH, increased GSSG, and greater oxidation as measured by the GSH redox potential, malondialdehyde, 8-isoprostane, and H 2 O 2 concentrations in the ELF. Given the antioxidant properties of GSH, further studies are needed to understand the impact of altered GSH homeostasis on asthma severity. Although previous studies have provided some support for the role of dietary antioxidants in allergic airway disease, the results of antioxidant supplementation studies have been largely disappointing. 38 However, these previous studies focused on clinical outcomes such as pulmonary function and did not take into account the effects of antioxidant therapy on extracellular antioxidant balance or intracellular signaling. 38 Given our findings of altered GSH homeostasis in severe asthma, additional studies are warranted to understand better the effects of airway GSH on respiratory morbidity. Ultimately, these data argue for interventions to increase ELF GSH concentrations in this population of children who are otherwise very difficult to treat. Diagram of airway glutathione homeostasis. ROOH and ROH represent organic hydroperoxides. 
